Skip to main content
OpenTrials
Completed

NCT Number: NCT04891575

Heart of the Family: A Cardiovascular Disease and Type 2 Diabetes Risk Reduction Intervention in High-Risk Rural Families

Rural populations in the U.S. are disproportionately burdened by cardiovascular disease and type 2 diabetes. Lifestyle modification interventions are needed that support long-term engagement in risk-reducing health behaviors. This trial will study the effects of a family-focused, lifestyle intervention that is culturally tailored for use with rural Hispanic and non-Hispanic adults. If successful, this community-based intervention has significant potential for broad dissemination to reduce cardiovascular disease and type 2 diabetes health disparities in rural U.S. communities.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

2201 Regency Rd.

Lexington, Kentucky, 40503, United States

About this study

The Heart of the Family study is a randomized controlled trial conducted to examine if a virtual lifestyle modification intervention is more effective in reducing risk for type 2 diabetes (T2D) and cardiovascular disease (CVD) when it is delivered to family dyads or to individuals and to compare intervention effects in Hispanic and non-Hispanic rural-dwelling adults at-risk for T2D or CVD. The Heart of the Family study will enroll 360 participants - 180 Hispanics and 180 non-Hispanics - from rural communities who have two or more risk factors for T2D or CVD. Participants will be randomized to participate as an individual or with a family member who may or may not be at risk for T2D or CVD or may or may not have diagnosed T2D or CVD for a total of 540 participants. The interventions for both groups will be provided by community health workers using a virtual platform. Both groups will receive eight educational sessions about healthy lifestyle behaviors and support to address personal and environmental barriers to engaging in healthy behaviors. After the eight sessions, the community health workers will follow up with participants once a month by phone over the next 12 months. Primary outcomes include short-term and long-term impact of the family-focused active intervention compared to the individual-focused control condition on type 2 diabetes and CVD biological risk factors (for example, blood pressure and weight) and behavioral risk factors (for example, physical activity and tobacco use). Outcomes are measured at baseline, immediately post-intervention, and at the end of the 12 month period of the study for both groups.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Primary participants are rural-dwelling Hispanic and non-Hispanic adults who are at-risk for type 2 diabetes or cardiovascular disease and have a family member who is willing to participate if the primary participant is randomly selected to participate with a family member.

Inclusion criteria

for the primary participant:

  • Is Hispanic or non-Hispanic adult
  • Is 18 years of age and older
  • Is a primary Spanish or English speaker
  • Has internet access
  • Has two or more risk factors for type 2 diabetes or cardiovascular disease including:
  • clinical diagnosis of hypertension;
  • clinical diagnosis of hyperlipidemia;
  • clinical diagnosis of prediabetes;
  • overweight or obese (body mass index ≥ 25 kg/m2);
  • is a current cigarette smoker;
  • male 45 years of age or older or female 55 years of age or older;
  • family history in first degree relative of type 2 diabetes or cardiovascular disease; or
  • is a female with a history of gestational diabetes mellitus or polycystic ovary syndrome.
  • Lives in rural Kentucky
  • Is willing to participate in the study for the next 12 months

Inclusion criteria

for the co-participating family member if primary participant is randomly selected to participate with a family member

  • Is 18 years of age and older
  • Is a primary Spanish or English speaker
  • Lives in the same household or in close proximity (no further than 25 miles distance) to the primary participant
  • Has internet access
  • Is willing to participate in the study for the next 12 months

Exclusion criteria

Exclusion criteria

for family dyads:

Primary participant and family member participant will be excluded if they:

  • Have cognitive impairment that preclude them from understanding the consent process, answering questionnaires, or participating in the intervention;
  • Have a major psychiatric (e.g., schizophrenia) condition;
  • Are pregnant or nursing or plan on becoming pregnant within the next year since dietary needs will be different.

Exclusion criteria

that apply only to the primary participant:

  • Have known coronary artery or cerebrovascular disease;
  • Have a diagnosis of type 1 or type 2 diabetes;
  • Have medical contraindications to participate in a lifestyle intervention that includes unsupervised physical activity and weight loss

Treatment and study plan

Active Control Intervention educational sessions

Behavioral

The participant will attend 8 sessions that provide type 2 diabetes (T2D) and cardiovascular (CVD) risk reduction and lifestyle modification education focused on CVD and T2D risk factor reduction through promotion of participant self-management. Education will concentrate on healthy eating, physical activity, stress reduction, and other lifestyle risk reduction recommendations.

Family Dyad Intervention

Behavioral

The participant and a co-participating family member will attend 8 sessions that provide type 2 diabetes (T2D) and cardiovascular (CVD) risk reduction and lifestyle modification education focused on CVD and T2D risk factor reduction through promotion of participant self-management. Education will concentrate on healthy eating, physical activity, stress reduction, and other lifestyle risk reduction recommendations.

Primary outcomes

  1. Change in body mass index (BMI)

    Time frame: 1 year (baseline, 3 months and 12 months)

    BMI based on measurements of weight and height and calculated as kg/m2.

  2. Change in blood pressure

    Time frame: 1 year (baseline, 3 months and 12 months)

    Blood pressure assessed using calibrated sphygmomanometry.

  3. Change in lipid profile

    Time frame: 1 year (at baseline, 3 months and 12 months)

    Lipid profile includes LDL-cholesterol, HDL-cholesterol and triglycerides measured using point-of-care testing obtained by fingerstick.

  4. Change in hemoglobin A1c (HbA1c)

    Time frame: 1 year (at baseline, 3 months and 12 months)

    HbA1c will be measured using point-of-care testing obtained by fingerstick.

  5. Change in physical activity level

    Time frame: 1 year (at baseline, 3 months and 12 months)

    Physical activity will be measured using the International Physical Activity Questionnaire (IPAQ) to assess the number of days in the last 7 days that the participant engaged in vigorous or moderate physical activity and confirmed by comparing responses to activity levels as determine through actigraphy.

  6. Change in dietary intake patterns

    Time frame: 1 year (at baseline, 3 months and 12 months)

    Dietary intake patterns will be assessed using the Vioscreen food frequency questionnaire.

  7. Change in tobacco use

    Time frame: 1 year (at baseline, 3 months and 12 months)

    Tobacco use will be confirmed by collection of a saliva sample to determine cotinine levels.

Sponsors and collaborators

Lead sponsor

Gia Mudd

Other

Collaborators

  • National Institute of Nursing Research (NINR)

Registry information

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
May 18, 2021
Registry last updated
Mar 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.